Director/PDMR Shareholding

RNS Number : 0750I
Anglo American PLC
30 March 2020
 

Anglo American plc ("the Company")

Registered office: 20 Carlton House Terrace, London SW1Y 5AN

Registered number: 3564138 (incorporated in England and Wales)

LEI: 549300S9XF92D1X8ME43

 

Notification of transactions by Directors and PDMRs

The Company announces the following transactions in its Ordinary Shares, pursuant to a Non-Executive Directors' 'Shares in lieu of fees' scheme. The Shares were acquired in the market using after-tax Directors' fees in respect of their services to the Company relating to the period 1 January - 31 March 2020.

 

In accordance with Article 19 of the EU Market Abuse Regulation, the relevant FCA notifications are set out below.

 

1.

Details of PDMR / person closely associated (PCA)

a)

Name

Stuart Chambers

2.

Reason for the notification

a)

Position / status

Chairman (Director/PDMR)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Anglo American plc

b)

LEI

549300S9XF92D1X8ME43

4.

Details of the transaction(s)

a)

Description of the financial instrument

 

Identification Code

Anglo American plc Ordinary Shares of USD0.54945 each

 

 

GB00B1XZS820

b)

Nature of the transaction

Purchase of Shares, pursuant to a Non-Executive Directors' 'Shares in lieu of fees' scheme

c)

Currency

GBP - British Pound

d)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP13.508

1,012

e)

Aggregated information

 

Aggregated volume

 

Price

 

 

1,012

 

GBP13.508  

f)

Date of the transaction

2020-03-27

g)

Place of the transaction

London Stock Exchange - XLON


1.

Details of PDMR / PCA

a)

Name

Mphu Ramatlapeng

2.

Reason for the notification

a)

Position / status

Non-Executive Director (Director/PDMR)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Anglo American plc

b)

LEI

549300S9XF92D1X8ME43

4.

Details of the transaction(s)

a)

Description of the financial instrument

 

Identification Code

Anglo American plc Ordinary Shares of USD0.54945 each

 

 

GB00B1XZS820

b)

Nature of the transaction

Purchase of Shares, pursuant to a Non-Executive Directors' 'Shares in lieu of fees' scheme

c)

Currency

GBP - British Pound

d)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP13.508

267

e)

Aggregated information

 

Aggregated volume

 

Price

 

 

267

 

GBP13.508

f)

Date of the transaction

2020-03-27

g)

Place of the transaction

London Stock Exchange - XLON

 

1.

Details of PDMR / PCA

a)

Name

Jim Rutherford

2.

Reason for the notification

a)

Position / status

Non-Executive Director (Director/PDMR)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Anglo American plc

b)

LEI

549300S9XF92D1X8ME43

4.

Details of the transaction(s)

a)

Description of the financial instrument

 

Identification Code

Anglo American plc Ordinary Shares of USD0.54945 each

 

 

GB00B1XZS820

b)

Nature of the transaction

Purchase of Shares, pursuant to a Non-Executive Directors' 'Shares in lieu of fees' scheme

c)

Currency

GBP - British Pound

d)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP13.508

1,686

e)

Aggregated information

 

Aggregated volume

 

Price

 

 

1,686

 

GBP13.508

f)

Date of the transaction

2020-03-27

g)

Place of the transaction

London Stock Exchange - XLON

 

 

Clare Davage

Deputy Company Secretary

30 March 2020

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFSLVRIIVII
UK 100